【研究名】 NARA Study 子宮筋腫手術前GnRHアンタゴニスト保存療法における隔日投与の有効性および忍容性に関する比較試験
【プロトコル論文】 The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial
Trials. 2024 Jan 19;25(1):68. doi: 10.1186/s13063-024-07923-2DOI: https://doi.org/ https://doi.org/10.1186/s13063-024-07923-2
【研究名】CAGUYAMA Study インヒビター非保有血友病A患者を対象とした、エミシズマブ投与下における破綻出血時/手術時止血管理における血液凝固第Ⅷ因子製剤投与時の凝固能測定に関する研究
【プロトコル論文】 Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trial
BMJ Open. 2023 Jul 10;13(7):e072565. doi: 10.1136/bmjopen-2023-072565.【研究名】HAL for PwH Study 止血異常症患者に対する装着型サイボーグHALを用いたリハビリテーション治療の有効性に関する単施設研究
【プロトコル論文】 Single-facility study of the effectiveness of rehabilitation therapy using wearable hybrid assistive limb for patients with bleeding disorders: study protocol for a randomised controlled trial
BMJ Open. 2023;13:e076153. doi:10.1136/bmjopen-2023-076153【研究名】COLE Study 口腔扁平苔癬に対するセファランチン🄬の有効性、安全性に関する多施設ランダム化比較試験
【プロトコル論文】 Cepharanthine and Oral Lichen Planus Efficacy (COLE) study: protocol for a multicentre randomised controlled study assessing the efficacy and safety of cepharanthine with topical corticosteroids in oral lichen planus
BMJ Open. 2023 Aug 16;13(8):e074279. doi: 10.1136/bmjopen-2023-074279.【研究名】NEO-NORMAL-AF study Heart Failure with non-reduced Ejection Fraction (HF non-rEF)症例を対象とした心房細動を含めた不整脈検出に対するImplantable Loop Recorder（ILR）の有用性の検討
【プロトコル論文】 Rationale and design of the NEO-NORMAL-AF study examination of the usefulness of implantable loop recorder for arrhythmia detection including atrial fibrillation in heart failure with non-reduced ejection fraction cases: a pilot study
Open Heart. 2023 Jul;10(2):e002193. doi: 10.1136/openhrt-2022-002193【研究名】ELEVATE study 頭頸部がん患者の治療に伴う嚥下機能障害に対する舌圧測定器（JMS舌圧測定器）の有用性の評価
【プロトコル論文】 Evaluation of usefulness of tongue pressure measurement device for dysphagia associated with treatment of patients with head and neck cancer (ELEVATE)
Medicine. 102(26):e33954, June 30, 2023.【研究名】Bolus-pCINC 重炭酸ナトリウムボーラス投与を用いた緊急経皮的冠動脈形成術後の造影剤腎症予防効果に関する臨床研究
【プロトコル論文】 Prevention of Contrast-Induced Nephropathy After Emergency Percutaneous Coronary Intervention With a Single Bolus Administration of High-Concentrate Sodium Bicarbonate ― Rationale and Design of a Single-Arm Study Compared With Historical Controls ―
Circ Rep. 2023 Mar 9;5(4):152-156. doi: 10.1253/circrep.CR-22-0105. eCollection 2023 Apr 10.【研究名】BIGSTEP Study 糖化ヘスペリジンの原発性胆汁性胆管炎患者に対する有効性と安全性についての研究
【プロトコル論文】 Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study.
Medicine (Baltimore). 2022 Dec 2;101(48):e32127. doi:10.1097/MD.0000000000032127
【研究名】FRAT Study 脳血管障害患者に対する機能的電気刺激を応用したリハビリテーション治療試験
【プロトコル論文】 Feasibility and acceptability of novel functional electronic stimulated rehabilitation application for treatment in patients with cerebrovascular disorders: the FRAT study protocol
Pilot Feasibility Stud. 2022 Dec 14;8(1):258. doi:10.1186/s40814-022-01217-7
【研究名】NOLDOR Study
ロボット支援腹腔鏡下前立腺全摘除術における目標指向型鎮痛管理がレミフェンタニル使用量に与える影響-無作為化比較試験-
【プロトコル論文】 Effect of NOciception Level-Directed analgesic management on Opioid usage in Robot-assisted laparoscopic radical prostatectomy (NOLDOR): study protocol for a single-centre single-blinded randomised controlled trial
BJA Open Volume 4, December 2022, 100112. doi:10.1016/j.bjao.2022.100112
【研究名】UNEBI Study インヒビター保有血友病A患者を対象とした、エミシズマブ投与下における破綻出血時/手術時止血管理におけるバイパス製剤投与時の凝固能測定に関する研究
【プロトコル論文】 Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial
BMJ Open 2022 Feb 17;12(2):e056922. doi: 10.1136/bmjopen-2021-056922
【研究名】ZEAL パーキンソン病の睡眠異常に対するゾニサミド（トレリーフ）の有効性に関するプラセボ対照、無作為化単盲検比較試験
【プロトコル論文】 Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials
Front Neurol. 2021 Dec 10;12:741307. doi: 10.3389/fneur.2021.741307. eCollection 2021.
【研究名】TARGET-UA 高尿酸血症を合併した慢性腎臓病患者に対する積極的尿酸降下療法の有効性を検証するランダム化比較試験 Trial of intensive UA-lowering therapy in CKD patients
【プロトコル論文】 Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial
Clin Exp Nephrol. 2020 Mar;24(3):235-241. doi: 10.1007/s10157-019-01815-5. Epub 2019 Nov 15.PMID: 31729647 DOI: 10.1007/s10157-019-01815-5
DOI: https://doi.org/10.1007/s10157-019-01815-5
【本論文】Multicenter randomized controlled trial of intensive uric acid lowering therapy for CKD patients with hyperuricemia: TARGET-UA
Clin Exp Nephrol.2024 Mar 26. doi: 10.1007/s10157-024-02483-w. Online ahead of print.【研究名】CANTABILE DPP-4阻害薬およびSGLT2阻害薬が2型糖尿病患者におけるメタボリックリスク因子に与える効果 Comparison of canagliflozin vs. tenegliptin against basic metabolic risks in patients with type 2 diabetes mellitus
【プロトコル論文】 Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial
Diabetes Ther. 2020 Jan;11(1):347-358. doi: 10.1007/s13300-019-00717-9. Epub 2019 Nov 1.PMID: 31677134 PMCID: PMC6965530 DOI: 10.1007/s13300-019-00717-9
DOI: https://doi.org/10.1007/s13300-019-00717-9
【本論文】Comparison of efficacy between dipeptidyl peptidase-4 inhibitor and sodium–glucose cotransporter 2 inhibitor on metabolic risk factors in Japanese patients with type 2 diabetes mellitus: Results from the CANTABILE study
Diabetes Res Clin Pract. 2021 Oct;180:109037. doi: 10.1016/j.diabres.2021.109037. Epub 2021 Sep 2.【研究名】CANONICAL 左室収縮性が保持された心不全合併高齢2型糖尿病患者におけるSGLT2阻害薬カナグリフロジンの有効性・安全性に及ぼす影響 Canagliflozin heart failure with preserved ejection fraction study in type 2 diabetes mellitus
【プロトコル論文】 Rationale and Design of the CANONICAL Study ― Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Canagliflozin for Heart Failure With Preserved Ejection Fraction With Type 2 Diabetes Mellitus ―
Circ Rep. 2019 Aug 3;1(8):347-351. doi: 10.1253/circrep.CR-19-0049.PMID: 33693161 PMCID: PMC7892479 DOI: 10.1253/circrep.CR-19-0049
DOI: https://doi.org/10.1253/circrep.CR-19-0049
【本論文】Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin for Heart Failure With Preserved Ejection Fraction in Patients With Type 2 Diabetes
Circulation Reports.CircRep2021;3: 440 – 448. doi: 10.1253/circrep.CR-21-0030